NCT00621868View on ClinicalTrials.gov

A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

March 26, 2008

Primary Completion Date

March 14, 2009

Study Completion Date

March 14, 2009

Conditions
Diabetes Mellitus
Interventions
DRUG

ipragliflozin

Oral

DRUG

Placebo

Oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaidou

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY